As reported previously, individual or combined use of small molecule inhibitors targeting PI3K, AKT, and mTOR, three main nodes of PI3K/AKT/mTOR signaling pathway, could achieve therapeutic effect on cancers (46). The gene discussed is MTOR; the disease is cancer.